Karp Capital Management’s DexCom DXCM Stock Holding History

Karp Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-400	Closed	-$12K	–	178
2018 Q4	$12K	Buy	+400	New	+$12.7K	0.01%	259

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Karp Capital Management's DXCM Position: Q1 2019 in Review

Karp Capital Management sold out of DexCom (DXCM) in Q1 2019, closing a stake of 400 shares — an estimated $12K sold.

Karp Capital Management first reported a position in DXCM in Q4 2018 and held it in 1 quarter. The position peaked at $12K in Q4 2018. 457 funds tracked by Wall St. Rank hold DXCM as of Q1 2019.

Karp Capital Management reported no remaining DexCom position as of Q1 2019 after selling out during the quarter.
Karp Capital Management sold 400 DexCom shares in Q1 2019, an estimated $12K.
Karp Capital Management first reported a position in DexCom in Q4 2018 and held it in 1 quarter.
Karp Capital Management's DexCom position peaked at $12K in Q4 2018.
457 funds tracked by Wall St. Rank held DexCom as of Q1 2019.

Based on Karp Capital Management's 13F filing for Q1 2019, filed 7 May 2019.